Donepezil for the symptomatic treatment
β
Anne Whitehead; Carlos Perdomo; Raymond D. Pratt; Jacqueline Birks; Gordon K. Wi
π
Article
π
2004
π
John Wiley and Sons
π
English
β 105 KB
π 3 views
## Abstract ## Background The objective was to evaluate the efficacy and tolerability of donepezil (5 and 10βmg/day) compared with placebo in alleviating manifestations of mild to moderate Alzheimer's disease (AD). ## Method A systematic review of individual patient data from Phase II and III do